Navigation Links
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
Date:6/17/2011

in the United States dedicated solely to mental health. Janssen currently markets prescription medications for the treatment of schizophrenia, Bipolar 1 Disorder, and schizoaffective disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a member of the Johnson & Johnson Family of Companies. For more information about Janssen, visit http://www.janssen.com.

About Patriot Pharmaceuticals, LLCPatriot Pharmaceuticals, LLC is a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.  The company markets and distributes authorized generic pharmaceuticals, including itraconazole, ketoconazole, galantamine, Tramadol HCl ER 100mg and 200mg and risperidone. Patriot is located in Horsham, PA.

Important Safety Information About RISPERDAL® and Risperidone Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis.

The most common adverse reactions observed in all clinical trials with RISPERDAL® occurring at a rate of at least 10% were drowsiness, increased appetite, fatigue, insomnia, sedation, tremor, muscle stiffness , vomiting, coughing, constipation, stuffy nose,  runny nose, drooling, dry mouth, abdominal pain, dizziness, nausea, anxiety, headache, nasal congestion , common cold, rash, and restlessness.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with RISPERDAL® and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has
'/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
2. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
3. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
4. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
5. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
7. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
8. Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months
9. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
10. Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Sept. 2, 2014   Mast Therapeutics, Inc . (NYSE MKT: ... M. Culley , will present at the Rodman and Renshaw 16 ... at 2:55 p.m. Eastern time in the Holmes II Salon at ... . Interested parties can access a live audio ... www.masttherapeutics.com . An archived presentation will be available on the ...
(Date:9/2/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a ... XIAFLEX ® in the U.S. and XIAPEX ® ... Wegman , will present at the following upcoming investor conferences. ... & Renshaw 16 th Annual Global Investment Conference ... 9, 2014 at 9:10 a.m. EDT , Aegis ...
(Date:9/2/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ... development of novel therapies for cancer, announced today ... Phase II clinical trial of its lead investigational ... patients with previously untreated intermediate-2 or high-risk myelodysplastic ... a total of 108 patients with a one-to-one ...
Breaking Medicine Technology:Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 3MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 4
... May 24, 2012   Hospira, Inc.  (NYSE: ... injectable drugs and infusion technologies, today released a ... integration of infusion pumps and electronic health records ... which recognizes the important work of healthcare technology ...
... Volcano Corporation (NASDAQ: VOLC ), a leading ... enhance the diagnosis and treatment of coronary and peripheral vascular ... Jefferies 2012 Global Healthcare Conference on Monday, June 4. ... begin at 8 a.m., Eastern Daylight Time (5 a.m., Pacific ...
Cached Medicine Technology:I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process 2I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process 3
(Date:9/2/2014)... How well patients recover from cancer surgery ... conditions and the operations themselves. Family conflicts and ... surgical complications, a Mayo Clinic study has found. ... reduce patients, stress, speed their recoveries and save ... specifically looked at colon cancer patients, and found ...
(Date:9/2/2014)... care for patients who are dying. A study of ... in training feel unprepared and anxious when faced with ... Scientists from the Sahlgrenska Academy have interviewed 222 nursing ... Skvde and the Ersta Skndal University College. The interviews ... their ideas about how to support and meet the ...
(Date:9/2/2014)... 02, 2014 Nanomedicine is essentially ... diagnosing, treating and/or prevention of diseases and infections. ... cardiovascular, neurological, and oncology diseases. , Nanomedicine ... to various nanoparticles, their medical usages, and their ... considerable scope for research in this domain, and ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The performance ... fluctuated over the past five years. Industry revenue is ... 1.0% over the five years through 2014-15, following stabilised ... faced increasing external competition from alternate forms of gambling. ... other online gambling platforms have all become increasingly popular ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group ... for its ICD-10 Medical Coding Bridge Program. The purpose ... of confidence to students who are seeking to launch ... faced with the uncertainty brought on by the federal ... October 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple ...
Breaking Medicine News(10 mins):Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2Health News:Many nurses unprepared to meet dying patients 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3
... ... and its staff members are helping to prepare Certified Professional Coders to meet the upcoming ... ... , a medical billing and practice management company, is pleased to announce that two of ...
... ... respirators universally fit faces, providing a better seal. Our product is available for retail ... our website. , ... Baxter, MN (PRWEB) October 9, 2009 -- Breathe Safely of Baxter Minnesota has created ...
... Sarasota Memorial ... application allows for voice, alarm and text messages to be delivered to the point of ... they have more time to spend caring for patients. , ... Sarasota,Fla (PRWEB) October 9, 2009 --Trey Lauderdale, Vice President ...
... Discussions Also to Feature Top Experts on the Battle Against H1N1 ... reform headed to the floor of the House and Senate, the ... discussions designed to shed light on what the looming changes will ... the Top of the Hill Banquet and Conference Center, at the ...
... time you run nutritionals using the government,s database, you might ... to have received a nutrient boost, virtually overnight. , The ... food entries - including mushrooms, the only fruit or vegetable ... updates made to the United States Department of Agriculture,s (USDA) ...
... League Baseball players have just learned they,re in the running for ... of 10 players, one of whom will go on to receive ... in January. The finalists for the 45th annual Hutch Award are: ... Torii Hunter, Los Angeles Angels of Anaheim Mark Lowe, ...
Cached Medicine News:Health News:Capture Billing Associates Elected to Local Chapter of the American Academy of Professional Coders 2Health News:Breathe Safely, LLC: Making Respirators 270% More Effective 2Health News:Sarasota Memorial Hospital Uses New Technology to Enhance Patient Experience 2Health News:Sarasota Memorial Hospital Uses New Technology to Enhance Patient Experience 3Health News:Tom Daschle, Richard Gephardt and Other Health Care Leaders to Diagnose Health Care Reform Battle in the Final Days of the Debate 2Health News:Tom Daschle, Richard Gephardt and Other Health Care Leaders to Diagnose Health Care Reform Battle in the Final Days of the Debate 3Health News:National Nutrient Database Updated to Include Vitamin D Values 2Health News:National Nutrient Database Updated to Include Vitamin D Values 3Health News:National Nutrient Database Updated to Include Vitamin D Values 4Health News:Ten Finalists Chosen for Hutch Award(R) 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: